# Pregnancy and epileptic seizures in the emergency department setting: A retrospective analysis

**Authors:** Yeliz Simsek, Ayşenur Gur

PMC · DOI: 10.1371/journal.pone.0339402 · PLOS One · 2026-01-20

## TL;DR

This study examines how pregnant women with seizures are treated in emergency departments and finds that antiseizure medications can help manage eclampsia.

## Contribution

The study provides insights into the management of epileptic seizures in pregnant patients and their association with eclampsia.

## Key findings

- Most patients were in their third trimester, with 69% having a history of epilepsy.
- Levetiracetam was the most commonly used antiseizure medication.
- ASM use showed benefits in managing suspected eclampsia cases.

## Abstract

This study evaluated the clinical features, management, and outcomes of pregnant women with generalized tonic-clonic seizures presenting to the emergency department (ED). The aim was to demonstrate how patients’ clinical features contribute to patient management and prognosis.

In this retrospective study, pregnant women over the age of 18 who presented to the ED with generalized tonic-clonic seizures were included. The patients’ demographic characteristics, clinical findings, treatments administered in the ED, and outcomes were recorded. Descriptive statistics, the chi-square tests or Fisher’s exact tests for categorical variables and the Mann–Whitney U or t-test for continuous variables were used in the statistical analysis.

The study included 48 patients, most of whom were in their third trimester. Thirty-three (69%) patients had a history of epilepsy, and 28 (58.3%) were using antiseizure medications (ASMs). The most commonly used ASM was levetiracetam. Seven (14.6%) patients had suspected eclampsia, and seizure control was achieved in four of them by administering ASMs in addition to magnesium sulfate treatment. Two (4.2%) patients developed status epilepticus (SE). A significant relationship was observed between gestational age and hospitalization (p = 0.005).

The diagnostic complexity of epileptic seizures in pregnancy complicates treatment choices, and ASM use may also be beneficial in managing eclampsia.

## Linked entities

- **Chemicals:** levetiracetam (PubChem CID 5284583), magnesium sulfate (PubChem CID 24083)
- **Diseases:** epilepsy (MONDO:0005027), eclampsia (MONDO:0001754)

## Full-text entities

- **Genes:** H19 (H19 imprinted maternally expressed transcript) [NCBI Gene 283120] {aka ASM, ASM1, BWS, D11S813E, GMRSP, LINC00008}
- **Diseases:** eclampsia (MESH:D004461), SE (MESH:D013226), seizure (MESH:D012640), epilepsy (MESH:D004827)
- **Chemicals:** levetiracetam (MESH:D000077287), magnesium sulfate (MESH:D008278), ASMs (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12818688/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12818688/full.md

## References

38 references — full list in the complete paper: https://tomesphere.com/paper/PMC12818688/full.md

---
Source: https://tomesphere.com/paper/PMC12818688